Milestones in the journey towards addressing obesity; Past trials and triumphs, recent breakthroughs, and an exciting future in the era of emerging effective medical …

M Kokkorakis, A Katsarou, N Katsiki, CS Mantzoros - Metabolism, 2023 - Elsevier
The 21st century is characterized by an increasing incidence and prevalence of obesity and
the burden of its associated comorbidities, especially cardiometabolic diseases, which are …

Usage of glucagon-like peptide-1 for obesity in children; updated review of Clinicaltrials. gov

NM Alorfi, FS Alshehri - Journal of Multidisciplinary Healthcare, 2023 - Taylor & Francis
Background Obesity in both adults and children is a primary health concern that can lead to
many complications at a young age, including insulin resistance, type 2 diabetes, and other …

Laparoscopic adjustable gastric banding with liraglutide in adults with obesity and type 2 diabetes (GLIDE): a pilot randomised placebo controlled trial

C Coelho, LJ Dobbie, J Crane, A Douiri… - International Journal of …, 2023 - nature.com
Introduction Obesity drives type 2 diabetes (T2DM) development. Laparoscopic adjustable
gastric banding (LAGB) has lower weight reduction than other bariatric procedures …

Glucagon-like peptide 1 receptor agonists: a medication for obesity management

MB Taha, T Yahya, P Satish, R Laird… - Current atherosclerosis …, 2022 - Springer
Abstract Purpose of Review The burden of obesity worldwide is high and projected to rise.
Obesity increases the risk of several cardiovascular diseases and cardiometabolic risk …

Pharmacologic management of weight regain following bariatric surgery

E Lucas, O Simmons, B Tchang… - Frontiers in Endocrinology, 2023 - frontiersin.org
While bariatric surgery restults in significant long-term weight loss for most patients with
obesity, post-surgical weight gain affects a considerable percentage of patients to varying …

Efficacy of liraglutide in non-diabetic obese adults: a systematic review and meta-analysis of randomized controlled trials

JJ Barboza, MR Huaman, B Melgar… - Journal of Clinical …, 2022 - mdpi.com
Objective: We systematically assessed the efficacy of liraglutide in non-diabetic obese
adults. Methods: Six databases were searched up to July 2021 for randomized controlled …

Pharmacotherapy as an augmentation to bariatric surgery for obesity

L Horváth, M Mráz, EB Jude, M Haluzík - Drugs, 2024 - Springer
A global obesity pandemic is one of the most significant health threats worldwide owing to its
close association with numerous comorbidities such as type 2 diabetes mellitus, arterial …

Glucagon-like peptide-1 receptor agonists in post-bariatric surgery patients: a systematic review and meta-analysis

D Dutta, L Nagendra, A Joshi, S Krishnasamy… - Obesity Surgery, 2024 - Springer
Background A significant number of patients face the issue of weight gain (WG) or
inadequate weight loss (IWL) post-bariatric surgery for obesity. Several studies have been …

How to address weight regain after bariatric surgery in an individualized way

RV Cohen, TBZ Petry - Reviews in Endocrine and Metabolic Disorders, 2023 - Springer
Bariatric surgery is the most effective obesity treatment. As a chronic and progressive
disease, weight loss response to surgery will vary individually. Thus, insufficient weight loss …

Literature review on antiobesity medication use for metabolic and bariatric surgery patients from the American Society for Metabolic and Bariatric Surgery Clinical …

RW Vosburg, M El Chaar, S El Djouzi… - Surgery for Obesity and …, 2022 - Elsevier
The following literature search is in response to inquiries made to the American Society for
Metabolic and Bariatric Surgery (ASMBS) regarding antiobesity medication (AOM) use in …